Cargando…
Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer
Colon cancer (CC) is among the most common malignant diseases with a dismal survival. Tumor necrosis factor-alpha (TNF-α) has been identified as a therapeutic target in various cancers, and anti-TNF-α treatment has shown promising effects in different cancer models. However, if TNF-α can be targeted...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055041/ https://www.ncbi.nlm.nih.gov/pubmed/27757041 http://dx.doi.org/10.2147/OTT.S109342 |